4.5 Article

AutoGrow 3.0: An improved algorithm for chemically tractable, semi-automated protein inhibitor design

期刊

JOURNAL OF MOLECULAR GRAPHICS & MODELLING
卷 44, 期 -, 页码 104-112

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jmgm.2013.05.006

关键词

Drug design; Click chemistry; Autogrow; Computational chemistry

资金

  1. NIH [GM31749]
  2. NSF [MCB-1020765]
  3. Howard Hughes Medical Institute
  4. NSF Supercomputer Centers
  5. San Diego Supercomputer Center
  6. W.M. Keck Foundation
  7. National Biomedical Computational Resource
  8. Center for Theoretical Biological Physics
  9. [MCA93S013]
  10. Direct For Mathematical & Physical Scien
  11. Division Of Physics [1308264] Funding Source: National Science Foundation

向作者/读者索取更多资源

We here present an improved version of AutoGrow (version 3.0), an evolutionary algorithm that works in conjunction with existing open-source software to automatically optimize candidate ligands for predicted binding affinity and other druglike properties. Though no substitute for the medicinal chemist, AutoGrow 3.0, unlike its predecessors, attempts to introduce some chemical intuition into the automated optimization process. AutoGrow 3.0 uses the rules of click chemistry to guide optimization, greatly enhancing synthesizability. Additionally, the program discards any growing ligand whose physical and chemical properties are not druglike. By carefully crafting chemically feasible druglike molecules, we hope that AutoGrow 3.0 will help supplement the chemist's efforts. To demonstrate the utility of the program, we use AutoGrow 3.0 to generate predicted inhibitors of three important drug targets: Trypanosoma brucei RNA editing ligase 1, peroxisome proliferator-activated receptor gamma, and dihydrofolate reductase. In all cases, AutoGrow generates druglike molecules with high predicted binding affinities. AutoGrow 3.0 is available free of charge (http://autogrow.ucsd.edu) under the terms of the GNU General Public License and has been tested on Linux and Mac OS X. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据